Show Menu

A fully integrated developer and manufacturer of polyclonal therapeutics, targeting infectious disease and acute toxic events

Single Investment Fund Award (SIF)

MicroPharm is pleased to announce that it has been awarded a SIF grant of £200,000 by the Welsh Assembly to support its continued research into new applications of therapeutic ovine polyclonal antibodies for the prevention and treatment of Clostridium  difficile infections.

Posted on: Wednesday, 18th August 2010